EOM Pharmaceuticals Holdings, Inc. (IMUC) Stock Price & Analysis
EOM Pharmaceuticals Holdings, Inc. (IMUC) closed at USD 0.04 on Friday, October 23, 2026, down 53.58% on the day. The US market is currently closed; this is not a live price.
The prior close was USD 0.1; the Oct 23, 2026 session ranged USD 0.04–0.04 on volume of 120 shares. Market capitalization is $5.58M, with a 52-week range of USD 0.02–0.27 (PNK). Source: Nexqual, retrieved October 24, 2026 at 02:20 UTC.
Also available as compact Markdown for AI agents: nexqual.com/IMUC.md
Key facts (IMUC)
- Analysts: None.
- Total return with dividends: 1Y -66.3% vs S&P 500 +13.4%; 5Y -93.4% vs S&P 500 +76.9%.
Analysts (IMUC)
Consensus None.
Total return (dividends reinvested) (IMUC)
| 1Y (from 2025-10-24) | 5Y (from 2021-10-25) | |
|---|---|---|
| Total return | -66.3% | -93.4% |
| S&P 500 (SPY) | +13.4% | +76.9% |
| Per year | -66.5% | -42.0% |
| Volatility (annualized) | 414.5% | 180.4% |
| Max drawdown | -83.7% (Jun 2026→Oct 2026) | -95.1% (Nov 2022→Oct 2026) |
IMUC analyst estimates and revisions
| Period | EPS estimate | 90 days ago | Change | Revenue estimate | Analysts |
|---|---|---|---|---|---|
| Current quarter | — | — | — | $0 | — |
| Next quarter | — | — | — | $0 | — |
| Current fiscal year | — | — | — | $0 | — |
| Next fiscal year | — | — | — | $0 | — |
Key Statistics (as of October 24, 2026 at 02:20 UTC)
| Price | USD 0.04 |
|---|---|
| Change | ▼ 53.58% (down) |
| Previous Close | USD 0.1 |
| Open | USD 0.04 |
| Day Range | USD 0.04 – 0.04 |
| 52-Week Range | USD 0.02 – 0.27 |
| Volume | 120 shares |
| Market Cap | $5.58M |
| Exchange | PNK |
Technical Analysis (IMUC)
Nexqual's technical model rates IMUC "SELL" based on 2 bullish and 5 bearish signals across 127 daily candles, as of October 24, 2026 at 02:20 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 32.34 (neutral) |
| vs SMA50 | Below (USD 0.15) |
| MACD | -0.02 (negative) |
Analyst Ratings (IMUC)
Wall Street analysts rate IMUC "None", per Nexqual as of October 24, 2026 at 02:20 UTC.
| Consensus Rating | None |
|---|
Earnings (IMUC)
Source: Nexqual, October 24, 2026 at 02:20 UTC.
Financials & Fundamentals (IMUC)
| Gross Margin | +0.00% |
|---|---|
| Operating Margin | +0.00% |
| Profit Margin | +0.00% |
| Current Ratio | 0.97 |
| Total Cash | $551,176 |
| Total Debt | $3.05M |
Source: Nexqual, October 24, 2026 at 02:20 UTC.
Financial Health Score (IMUC)
Nexqual rates EOM Pharmaceuticals Holdings, Inc.'s overall financial health "Weak" across five dimensions, as of October 24, 2026 at 02:20 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Weak — Gross margin 0%, operating 0% (last 12 months) |
| Balance Sheet | Mixed — $551K cash vs $3M debt |
| Cash Flow | Weak — Operating cash flow -$3M (TTM) |
| Efficiency | Mixed — No data |
Ownership (IMUC)
| Insider Ownership | +94.97% |
|---|---|
| Institutional Ownership | +0.00% |
| Shares Outstanding | 126.50M |
| Float | 5.70M |
| Short % of Float | +3.96% |
Source: Nexqual, October 24, 2026 at 02:20 UTC.
Leadership (IMUC)
EOM Pharmaceuticals Holdings, Inc. is led by Irach B. Taraporewala B.S., M.S., CEO, President & Director, per Nexqual as of October 24, 2026 at 02:20 UTC.
| CEO, President & Director | Irach B. Taraporewala B.S., M.S. |
|---|---|
| CFO & Treasurer | Wayne I. Danson |
| Founder, Chairman & COO | Eli Goldberger |
| Co-Founder, Chief Scientific Officer & Medical Director | Shalom Z. Hirschman |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| LGND | Ligand Pharmaceuticals Incorpor | USD 303.53 | ▼ 1.39% |
| RYTM | Rhythm Pharmaceuticals, Inc. | USD 89.27 | ▼ 1.79% |
| IOVA | Iovance Biotherapeutics, Inc. | USD 14.09 | ▼ 0.35% |
| PRAX | Praxis Precision Medicines, Inc | USD 252.96 | ▼ 2.3% |
| IONS | Ionis Pharmaceuticals, Inc. | USD 42.93 | ▼ 2.23% |
| AXSM | Axsome Therapeutics, Inc. | USD 145.04 | ▼ 7.07% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 24, 2026 at 02:20 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt